Vertex Pharmaceuticals Incorporated (ETR:VX1)
Germany · Delayed Price · Currency is EUR 352.35
-8.65 (-2.40%)
Nov 7, 2025, 5:35 PM CET
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of €91.54 billion as of November 7, 2025. Its market cap has decreased by -19.24% in one year.
Market Cap
91.54B
Enterprise Value
82.72B
Revenue
9.99B
Ranking
n/a
PE Ratio
29.23
Stock Price
€352.35
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 73.88M to 91.54B, an increase of 123,802.25%. That is a compound annual growth rate of 23.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 91.54B | -8.61% |
| Dec 31, 2024 | 100.17B | 5.60% |
| Dec 29, 2023 | 94.86B | 36.76% |
| Dec 30, 2022 | 69.36B | 41.28% |
| Dec 31, 2021 | 49.09B | -2.28% |
| Dec 31, 2020 | 50.24B | 0.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Siemens Healthineers AG | 54.80B |
| Merck KGaA | 49.00B |
| Fresenius SE & Co. KGaA | 27.33B |
| Bayer Aktiengesellschaft | 26.28B |
| Sartorius Aktiengesellschaft | 14.33B |
| Fresenius Medical Care AG | 11.92B |
| Fielmann Group AG | 3.92B |
| Carl Zeiss Meditec AG | 3.76B |